Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy

ObjectiveThe gain of function (GOF) CTNNB1 mutations (CTNNB1GOF) in hepatocellular carcinoma (HCC) cause significant immune escape and resistance to anti-PD-1. Here, we aimed to investigate the mechanism of CTNNB1GOF HCC-mediated immune escape and raise a new therapeutic strategy to enhance anti-PD-...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Gut Ročník 73; číslo 6; s. 985 - 999
Hlavní autori:	Cai, Ning, Cheng, Kun, Ma, Yue, Liu, Sha, Tao, Ran, Li, Yani, Li, Danfeng, Guo, Bin, Jia, Wenlong, Liang, Huifang, Zhao, Jianping, Xia, Limin, Ding, Ze-yang, Chen, Jinhong, Zhang, Wanguang
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.06.2024 BMJ Publishing Group LTD BMJ Publishing Group
Edícia:	Original research
Predmet:	Animal models Animals beta Catenin - genetics beta Catenin - metabolism CANCER IMMUNOBIOLOGY Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - pathology CD8 antigen CD8-Positive T-Lymphocytes - immunology Cell Line, Tumor Cell-mediated immunity Chemokine receptors Chemokines Consortia CXCR3 protein Cytotoxicity Datasets Dendritic cells Down-regulation Flow cytometry G protein-coupled receptors Gelatinase B Gene flow Genes Genomes HEPATOCELLULAR CARCINOMA Hepatology Humans Immune Checkpoint Inhibitors - pharmacology Immune Checkpoint Inhibitors - therapeutic use Immune evasion IMMUNOTHERAPY Intracellular signalling Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - genetics Liver Neoplasms - immunology Liver Neoplasms - pathology Lymphocytes Lymphocytes T Matrix Metalloproteinase 9 - genetics Matrix Metalloproteinase 9 - metabolism Medical prognosis Metalloproteinase Metastases Mice Microenvironments Mutation MUTATIONS PD-1 protein Phosphoprotein phosphatase Plasmids Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - metabolism Protein phosphatase Proteins Proteomics Transcription activation Tumor Escape - drug effects Tumor Escape - genetics Tumor Microenvironment - immunology Tumors β-Catenin CANCER IMMUNOBIOLOGY MUTATIONS IMMUNOTHERAPY HEPATOCELLULAR CARCINOMA
ISSN:	0017-5749, 1468-3288, 1468-3288
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!